TIPS-03 A PHASE 1 STUDY OF GALLIUM MALTOLATE (GAM) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

Glioblastoma remains the most aggressive malignant brain tumor with universally poor prognosis. New treatments are needed which target novelpathways. GBM cells have significantly greater requirements for iron and display markedly higher levels of transferrin receptors for iron uptake and ferritin fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Connelly, Jennifer, Schmainda, Kathleen, Al-Gizawiy, Mona, Santos-Pinhero, Fernando, Chitambar, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Trials in Progress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402361/
http://dx.doi.org/10.1093/noajnl/vdad070.134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402361/
http://dx.doi.org/10.1093/noajnl/vdad070.134

Ejemplares similares